Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 63, Issue 4 , Pages 603-609 , April 2010

Baseline Quality of Life in patients with Klippel–Trenaunay syndrome

  • Charlène E.U. Oduber

      Affiliations

    • Department of Plastic, Reconstructive and Hand Surgery, Academic Medical Centre, Amsterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Academic Medical Centre, University of Amsterdam, Department of Plastic, Reconstructive and Hand Surgery, P.O. Box 22700, 1100 DD Amsterdam, The Netherlands. Tel.: +31 20 566 2974; fax: +31 20 691 7549.
    • ,
  • Kavita Khemlani

      Affiliations

    • Department of Plastic, Reconstructive and Hand Surgery, Academic Medical Centre, Amsterdam, The Netherlands
    • ,
  • J. Henk Sillevis Smitt

      Affiliations

    • Department of Dermatology, Academic Medical Center, University of Amsterdam, The Netherlands
    • ,
  • Raoul C.M. Hennekam

      Affiliations

    • Department of Paediatrics, Academic Medical Centre, Amsterdam, The Netherlands
    • Clinical and Molecular Genetics Unit, Institute of Child Health, Great Ormond Street Hospital for Children, UCL, London, UK
    • ,
  • Chantal M.A.M. van der Horst

      Affiliations

    • Department of Plastic, Reconstructive and Hand Surgery, Academic Medical Centre, Amsterdam, The Netherlands

Received 9 September 2008 ,Accepted 30 January 2009.

References 

  1. Lorda-Sanchez I, Prieto L, Rodriguez-Pinilla E, et al. Increased parental age and number of pregnancies in Klippel–Trenaunay–Weber syndrome. Ann Hum Genet. 1998;62:235
  2. Higurashi M, Oda M, Iijima K, et al. Livebirth prevalence and follow-up of malformation syndromes in 27,472 newborns. Brain Dev. 1990;12:770
  3. Klippel M, Trenaunay P. Memoires originaux: du naevus variqeux osteo-hypertrophique. Arch Gen Med. 1900;Tome III:641
  4. Oduber CE, van der Horst CM, Hennekam RC. Klippel–Trenaunay syndrome: diagnostic criteria and hypothesis on etiology. Ann Plast Surg. 2008;60:217
  5. van der Ploeg HM, van der Ploeg MNS, van der Ploeg-Stapert JD. Psychological aspects of the Klippel–Trenaunay syndrome. J Psychosom Res. 1995;39:183
  6. van der Ploeg MN, Hulsmans RF, van der Ploeg HM, et al. Klippel-Trenaunay–type congenital angiodysplasia syndrome; medical and psychological aspects. Ned Tijdschr Geneeskd. 1996;140:2502
  7. Jacob AG, Driscoll DJ, Shaughnessy WJ, et al. Klippel Trenaunay syndrome: spectrum and management. Mayo Clin Proc. 1998;73:28
  8. Baskerville PA, Ackroyd JS, Lea Thomas M. The Klippel–Trenaunay syndrome: clinical, radiological and haemodynamic features and management. Br J Surg. 1985;72:232
  9. Oduber CE, Gerdes VE, van der Horst CM, et al. Vascular malformations as underlying cause of chronic thromboembolism and pulmonary hypertension. J Plast Reconstr Aesthet Surg. 2009;62:684–689
  10. Breugem CC, Merkus MP, Smitt HS, et al. Quality of life in patients with vascular malformations of the lower extremity. Br J Plast Surg. 2004;57:754
  11. Finlay AY. Quality of life assessment in dermatology. Semin Cutan Med Surg. 1998;17:291
  12. Van der Horst CMAM, de Borgie CAJM, Knopper JL, et al. Psychosocial adjustment of children and adults with port wine stains. Br J Plast Surg. 1997;50:463
  13. Shakespeare V, Shakespeare P, Cole RP. Measuring patient satisfaction with pulsed dye laser treatment of vascular lesions. Lasers Med Sci. 1998;13:253
  14. Pasculli G, Resta F, Guastamacchia E, et al. Health-related quality of life in a rare disease: Hereditary hemorrhagic telangiectasia (HHT) or Rendu–Osler–Weber disease. Qual Life Res. 2004;13:1715
  15. Page PZ, Page GP, Ecosse E, et al. Impact of neurofibromatosis 1 on quality of life: a cross-sectional study of 176 American cases. Am J Med Gen Part A. 2006;140A:1893
  16. Wolkenstein P, Zeller J, Revuz J, et al. Quality-of-life impairment in neurofibromatosis type 1. Arch Dermatol. 2001;137:1421
  17. Sampogna F, Tabolli S, Söderfeldt B, et al., IDI Multipurpose Psoriasis Research on Vital Experiences (IMPROVE) investigators  Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol. 2006;154:844
  18. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473
  19. Available from: http://www.sf-36.com
  20. The Dutch Version of the Skindex-29 Manual. Een dermatologiespecifieke kwaliteit-van-leven vragenlijst. Stichting Aquamarijn; May 2005;Available from: http://www.stichtingaquamarijn.nlVersion 1
  21. Legierse CM, de Korte J, Prinsen CAC. Quality of Life Assessment in Dermatological Practice using the Dutch Version of the (Electronic) Skindex-29 – a Manual. Stichting Aquamarijn; June 2008;Available from: www.stichtingaquamarijn.nlVersion 1
  22. Chren MM, Lasek RJ, Quinn LM, et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. J Invest Dermatol. 1996;107:707
  23. Abeni D, Picardi A, Pasquini P, et al. Further evidence of the validity and reliability of the Skindex-29: an Italian study on 2,242 dermatological outpatients. Dermatology. 2002;204:43
  24. Boetes C, Boll AP, Hartman PH, et al. Comment on: psychological aspects of the Klippel–Trenaunay syndrome. Ned Tijdschr Geneeskd. 1997;141:650
  25. Book: Mulliken JB, Young AE, editors. Vascular Birthmarks: Hemangiomas and Malformations. Philadelphia: W.B. Saunders Company.
  26. Touw CR, Hakkaart-Van Roijen L, Verboom P, et al. Quality of life and clinical outcome in psoriasis patients using intermittent cyclosporine. Br J Dermatol. 2001;144:967
  27. Fortune DG, Main CJ, O'Sullivan TM, et al. Assessing illness-related stress in psoriasis: the psychometric properties of the psoriasis life stress inventory. J Psychosom Res. 1997;42:467
  28. Weiss SC, Kimball AB, Liewehr DJ, et al. Quantifying the harmful effect of psoriasis on health-related quality of life. J Am Acad Dermatol. 2002;47:512
  29. Finlay AY, Kelly SE. Psoriasis: an index of disability. Clin Exp Dermatol. 1987;12:8
  30. Finlay AY, Khan GK, Luscombe DK, et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol. 1990;123:751
  31. Salek MS, Finlay AY, Luscombe DK, et al. Cyclosporin greatly improves the quality of life of adults with severe atopic dermatitis. A randomized, double-blind, placebo-controlled trial. Br J Dermatol. 1993;129:422
  32. Fortune DG, Main CJ, O'Sullivan TM, et al. Quality of life in patients with psoriasis: the contribution of clinical variables and psoriasis-specific stress. Br J Dermatol. 1997;137:755
  33. McKenna KE, Stern RS. The impact of psoriasis on the quality of life of patients from the 16-center PUVA follow-up cohort. J Am Acad Dermatol. 1997;36:388
  34. De Korte J, Mombers FM, Sprangers MA, et al. The suitability of quality-of-life questionnaires for psoriasis research: a systematic literature review. Arch Dermatol. 2002;138:1221;[discussion 1227]
  35. Sampogna F, Picardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66:620
  36. Both H, Essink-Bot ML, Busschbach J, et al. Critical review of generic and dermatology-specific health-related quality of life instruments. J Invest Dermatol. 2007;127:2726

PII: S1748-6815(09)00152-1

doi: 10.1016/j.bjps.2009.01.055

Journal of Plastic, Reconstructive & Aesthetic Surgery
Volume 63, Issue 4 , Pages 603-609 , April 2010

Article Tools

* Image Usage & Resolution